Therapy
Biotechnology
Medical

Dermira

$9.95
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (2.37%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell Dermira and other stocks, options, ETFs, and crypto commission-free!

About

Dermira, Inc. Common Stock, also called Dermira, is a biopharmaceutical company, which engages in the provision of therapies for chronic skin conditions. Read More It focuses on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis and atopic dermatitis. The company was founded by Thomas G. Wiggans, Eugene Andrew Bauer, Luis C. Peña, and Christopher M. Griffith on August 18, 2010 and is headquartered in Menlo Park, CA.

Employees
333
Headquarters
Menlo Park, California
Founded
2010
Market Cap
533.65M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.06M
High Today
$10.07
Low Today
$9.70
Open Price
$9.75
Volume
184.84K
52 Week High
$15.48
52 Week Low
$6.00

Collections

Therapy
Biotechnology
Medical
Biopharmaceutical
Pharmaceutical
Health
2014 IPO

News

Yahoo FinanceMay 8

Did You Manage To Avoid Dermira's (NASDAQ:DERM) Painful 63% Share Price Drop?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! It is doubtless a positive to see that the Dermira, Inc. (NASDAQ:DERM) share price has gained some 52% in the last three months. But over the last three years we've seen a quite serious decline. Indeed, the share price is down a tragic 63% in the last three years. So it's good to see it climbing back up. While many would remain nervous, there could be further gains if the business can...

219
Yahoo FinanceMay 7

Dermira: 1Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Dermira Inc. (DERM) on Tuesday reported a loss of $64.8 million in its first quarter. The Menlo Park, California-based company said it had a loss of $1.49 per share. The skin condition drug developer posted revenue of $2.5 million in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $2.6 million. Dermira shares have risen 46% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $10.50, a climb of roughly 4...

17
Simply Wall StMay 7

How Many Dermira, Inc. (NASDAQ:DERM) Shares Do Institutions Own?

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! A look at the shareholders of Dermira, Inc. (NASDAQ:DERM) can tell us which group is most powerful. Institutions will often hold stock in bigger companies, and we expect to see insiders owning a noticeable percentage of the smaller ones. We also tend to see lower insider ownership in companies that were previously publicly owned. Dermira is not a large company by global standards. It...

4

Earnings

-$1.74
-$1.33
-$0.92
-$0.51
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 5, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.